Adam JacksonDecember 15, 2023
Awakn partnered with Orphan Insight Ltd., which provides consulting on bringing novel drug therapies to market.
Tag: Awakn Life Sciences
Adam JacksonDecember 15, 2023Adam JacksonOctober 4, 2023
Research results indicated positive signals.
Adam JacksonApril 28, 2023
The firm has made meaningful strides in its early clinical runway as it gears up for government-funded studies.
Debra BorchardtApril 13, 2023
While not illegal, some people are vehemently opposed to the practice.
John SchroyerApril 12, 2023The company also opened a new clinic in Norway.
Adam JacksonFebruary 9, 2023The OTC asked the company to clarify if it had engaged in "pump-and-dump" schemes.
Dave HodesDecember 21, 2022
Also a peek at their plans for the year ahead.
Dave HodesOctober 10, 2022
There’s been a steady surge of interest in how and why psychedelics work to potentially cure addiction, especially alcohol addiction, also called alcohol use disorder (AUD). It is becoming one of the more interesting developments that mainstream medicine is watching, as more and more evidence becomes available. In fact, it was LSD that was the original […]
Adam JacksonSeptember 15, 2022Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) posted positive results as revenue rose along with patients — showing the growing demand for psychedelics-centered therapy to treat addictions. The Canadian biotechnology company released its financial report card for the second quarter ending July 31. Awakn posted revenues of C$339,872 via Awakn’s clinics for the second […]
StaffJune 15, 2022Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) reported its financial results for the first quarter ending April 30, 2022. Awakn recorded revenue of $253,154 via Awakn’s clinics versus zero in the prior year. This represents a 23.9% or $48,834 versus the three months ended January 31, 2022. The company said the revenue was primarily […]
Get the latest cannabis news delivered right to your inbox
Unpack the industry with the daily cannabis newsletter for business leaders.